Phospholemman Ser69 phosphorylation contributes to sildenafil-induced cardioprotection against reperfusion injury

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 299, Issue 3, 2010, Pages

  Madhani, Melanie ^a   Hall, Andrew R ^b   Cuello, Friederike ^b   Charles, Rebecca L ^b   Burgoyne, Joseph R ^b   Fuller, William ^c   Hobbs, Adrian J ^d   Shattock, Michael J ^b   Eaton, Philip ^b  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b ST THOMAS HOSPITAL   (United Kingdom)

^c UNIVERSITY OF DUNDEE   (United Kingdom)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Heart; Ischemia; Protein kinase G; Sodium potassium adenosine 5 triphosphatase

Indexed keywords

8 BROMO CYCLIC GMP; ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); BISINDOLYLMALEIMIDE; KT 5823; PHOSPHOLEMMAN; PROTEIN; RUBIDIUM; SILDENAFIL; UNCLASSIFIED DRUG; CARDIOTONIC AGENT; MEMBRANE PROTEIN; PHOSPHOPROTEIN; PIPERAZINE DERIVATIVE; PURINE DERIVATIVE; SULFONE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; ENZYME ACTIVATION; FLAME PHOTOMETRY; HEART INFARCTION; HEART MUSCLE INJURY; HEART MUSCLE REPERFUSION; HEART PROTECTION; ISOLATED HEART; MALE; MOUSE; NONHUMAN; PATCH CLAMP; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REPERFUSION INJURY; WESTERN BLOTTING; ANALYSIS OF VARIANCE; ANIMAL; CELL CULTURE; DRUG EFFECTS; HEART; HEART MUSCLE; METABOLISM; MUSCLE CELL; PHOSPHORYLATION; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ANALYSIS OF VARIANCE; ANIMALS; BLOTTING, WESTERN; CARDIOTONIC AGENTS; CELLS, CULTURED; HEART; MEMBRANE PROTEINS; MICE; MUSCLE CELLS; MYOCARDIUM; PHOSPHOPROTEINS; PHOSPHORYLATION; PIPERAZINES; PURINES; REPERFUSION INJURY; SIGNAL TRANSDUCTION; SODIUM-POTASSIUM-EXCHANGING ATPASE; SULFONES;

EID: 77955721011     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00129.2010     Document Type: Article

References (49)

1. Angelone T, Filice E, Quintieri AM, Imbrogno S, Recchia A, Pulera E, Mannarino C, Pellegrino D, Cerra MC. Beta3-adrenoceptors modulate left ventricular relaxation in the rat heart via the NO-cGMP-PKG pathway. Acta Physiol (Oxf) 193: 229-239, 2008. (Pubitemid 351783190)
2. Bender AT, Beavo JA. Cyclic nucleotide phosphodiesterases: molecular regulation to clinical use. Pharmacol Rev 58: 488-520, 2006.
3. Bremer YA, Salloum F, Ockaili R, Chou E, Moskowitz WB, Kukreja RC. Sildenafil citrate (viagra) induces cardioprotective effects after ischemia/reperfusion injury in infant rabbits. Pediatr Res 57: 22-27, 2005.
4. Castro LR, Verde I, Cooper DM, Fischmeister R. Cyclic guanosine monophosphate compartmentation in rat cardiac myocytes. Circulation 113: 2221-2228, 2006. (Pubitemid 43755145)
5. Costa AD, Garlid KD, West IC, Lincoln TM, Downey JM, Cohen MV, Critz SD. Protein kinase G transmits the cardioprotective signal from cytosol to mitochondria. Circ Res 97: 329-336, 2005.
6. Das A, Xi L, Kukreja RC. Phosphodiesterase-5 inhibitor sildenafil preconditions adult cardiac myocytes against necrosis and apoptosis. Essential role of nitric oxide signaling. J Biol Chem 280: 12944-12955, 2005.
7. Das A, Xi L, Kukreja RC. Protein kinase G-dependent cardioprotective mechanism of phosphodiesterase-5 inhibition involves phosphorylation of ERK and GSK3beta. J Biol Chem 283: 29572-29585, 2008.
8. Das S, Maulik N, Das DK, Kadowitz PJ, Bivalacqua TJ. Cardioprotection with sildenafil, a selective inhibitor of cyclic 3′,5′- monophosphate-specific phosphodiesterase 5. Drugs Exp Clin Res 28: 213-219, 2002. (Pubitemid 36596885)
9. Dirksen MT, Laarman GJ, Simoons ML, Duncker DJ. Reperfusion injury in humans: a review of clinical trials on reperfusion injury inhibitory strategies. Cardiovasc Res 74: 343-355, 2007.
10. du Toit EF, Rossouw E, Salie R, Opie LH, Lochner A. Effect of sildenafil on reperfusion function, infarct size, and cyclic nucleotide levels in the isolated rat heart model. Cardiovasc Drugs Ther 19: 23-31, 2005.
11. Elrod JW, Greer JJ, Lefer DJ. Sildenafil-mediated acute cardioprotection is independent of the NO/cGMP pathway. Am J Physiol Heart Circ Physiol 292: H342-H347, 2007.
12. Forfia PR, Lee M, Tunin RS, Mahmud M, Champion HC, Kass DA. Acute phosphodiesterase 5 inhibition mimics hemodynamic effects of B-type natriuretic peptide and potentiates B-type natriuretic peptide effects in failing but not normal canine heart. J Am Coll Cardiol 49: 1079-1088, 2007.
13. Fuller W, Howie J, McLatchie LM, Weber RJ, Hastie CJ, Burness K, Pavlovic D, Shattock MJ. FXYD1 phosphorylation in vitro and in adult rat cardiac myocytes: threonine 69 is a novel substrate for protein kinase C. Am J Physiol Cell Physiol 296: C1346-C1455, 2009.
14. Fuller W, Parmar V, Eaton P, Bell JR, Shattock MJ. Cardiac ischemia causes inhibition of the Na/K ATPase by a labile cytosolic compound whose production is linked to oxidant stress. Cardiovasc Res 57: 1044-1051, 2003.
15. Hausenloy DJ, Yellon DM. Preconditioning and postconditioning: united at reperfusion. Pharmacol Ther 116: 173-191, 2007.
16. Hobbs AJ. Soluble guanylate cyclase: an old therapeutic target re-visited. Br J Pharmacol 136: 637-640, 2002.
17. Hofmann F, Feil R, Kleppisch T, Schlossmann J. Function of cGMP-dependent protein kinases as revealed by gene deletion. Physiol Rev 86: 1-23, 2006.
18. Kass DA, Champion HC, Beavo JA. Phosphodiesterase type 5: expanding roles in cardiovascular regulation. Circ Res 101: 1084-1095, 2007.
19. Kemp BE, Pearson RB. Protein kinase recognition sequence motifs. Trends Biochem Sci 15: 342-346, 1990. (Pubitemid 20255495)
20. Krieg T, Liu Y, Rutz T, Methner C, Yang XM, Dost T, Felix SB, Stasch JP, Cohen MV, Downey JM. BAY 58-2667, a nitric oxidein-dependent guanylyl cyclase activator, pharmacologically post-conditions rabbit and rat hearts. Eur Heart J 30: 1607-1613, 2009.
21. Krieg T, Philipp S, Cui L, Dostmann WR, Downey JM, Cohen MV. Peptide blockers of PKG inhibit ROS generation by acetylcholine and bradykinin in cardiomyocytes but fail to block protection in the whole heart. Am J Physiol Heart Circ Physiol 288: H1976-H1981, 2005.
22. Kupriyanov VV, Xiang B, Sun J, Jilkina O, Kuzio B. Imaging of ischemia and infarction in blood-perfused pig hearts using 87Rb MRI. Magn Reson Med 49: 99-107, 2003.
23. Lansbery KL, Burcea LC, Mendenhall ML, Mercer RW. Cytoplasmic targeting signals mediate delivery of phospholemman to the plasma membrane. Am J Physiol Cell Physiol 290: C1275-C1286, 2006.
24. Maack T. Role of atrial natriuretic factor in volume control. Kidney Int 49: 1732-1737, 1996. (Pubitemid 26186603)
25. Maas O, Donat U, Frenzel M, Rutz T, Kroemer HK, Felix SB, Krieg T. Vardenafil protects isolated rat hearts at reperfusion dependent on GC and PKG. Br J Pharmacol 154: 25-31, 2008.
26. Nagayama T, Hsu S, Zhang M, Koitabashi N, Bedja D, Gabrielson KL, Takimoto E, Kass DA. Sildenafil stops progressive chamber, cellular, and molecular remodeling and improves calcium handling and function in hearts with pre-existing advanced hypertrophy caused by pressure overload. J Am Coll Cardiol 53: 207-215, 2009.
27. Neubauer S, Newell JB, Ingwall JS. Metabolic consequences and predictability of ventricular fibrillation in hypoxia. A 31P- and 23Na-nuclear magnetic resonance study of the isolated rat heart. Circulation 86: 302-310, 1992.
28. ATP channels in rabbits. Am J Physiol Heart Circ Physiol 283: H1263-H1269, 2002.
29. ATP channel opening and leads to cardioprotection. Am J Physiol Heart Circ Physiol 286: H468-H476, 2004.
30. Palmer CJ, Scott BT, Jones LR. Purification and complete sequence determination of the major plasma membrane substrate for cAMP-dependent protein kinase and protein kinase C in myocardium. J Biol Chem 266: 11126-11130, 1991.
31. Pavlovic D, Fuller W, Shattock MJ. The intracellular region of FXYD1 is sufficient to regulate cardiac Na/K ATPase. FASEB J 21: 1539-1546, 2007.
32. Rakhit RD, Marber MS. Nitric oxide: an emerging role in cardioprotection? Heart 86: 368-372, 2001. (Pubitemid 32889367)
33. Salloum F, Yin C, Xi L, Kukreja RC. Sildenafil induces delayed preconditioning through inducible nitric oxide synthase-dependent pathway in mouse heart. Circ Res 92: 595-597, 2003.
34. ATP channels when administered at reperfusion following ischemia in rabbits. J Mol Cell Cardiol 42: 453-458, 2007.
35. + exchanger NHE1. J Biol Chem 281: 20252-20262, 2006.
36. Stasch JP, Hobbs AJ. NO-independent, haem-dependent soluble guanylate cyclase stimulators. Handb Exp Pharmacol 191: 277-308, 2009.
37. Su J, Scholz PM, Weiss HR. Differential effects of cGMP produced by soluble and particulate guanylyl cyclase on mouse ventricular myocytes. Exp Biol Med (Maywood) 230: 242-250, 2005.
38. 2+ exchange. Circ Res 65: 1045-1056, 1989.
39. Tanno M, Bassi R, Gorog DA, Saurin AT, Jiang J, Heads RJ, Martin JL, Davis RJ, Flavell RA, Marber MS. Diverse mechanisms of myocardial p38 mitogen-activated protein kinase activation: evidence for MKK-independent activation by a TAB1-associated mechanism contributing to injury during myocardial ischemia. Circ Res 93: 254-261, 2003.
40. Valtcheva N, Nestorov P, Beck A, Russwurm M, Hillenbrand M, Weinmeister P, Feil R. The commonly used cGMP-dependent protein kinase type I (cGKI) inhibitor Rp-8-Br-PET-cGMPS can activate cGKI in vitro and in intact cells. J Biol Chem 284: 556-562, 2009.
41. van Echteld CJ, Kirkels JH, Eijgelshoven MH, van der Meer P, Ruigrok TJ. Intracellular sodium during ischemia and calcium-free perfusion: a 23Na NMR study. J Mol Cell Cardiol 23: 297-307, 1991.
42. Walaas SI, Czernik AJ, Olstad OK, Sletten K, Walaas O. Protein kinase C and cyclic AMP-dependent protein kinase phosphorylate phospholemman, an insulin and adrenaline-regulated membrane phosphoprotein, at specific sites in the carboxy terminal domain. Biochem J 304: 635-640, 1994. (Pubitemid 24368248)
43. + pump in isolated rabbit cardiac myocytes. J Physiol 565: 815-825, 2005.
44. Wilson LS, Elbatarny HS, Crawley SW, Bennett BM, Maurice DH. Compartmentation and compartment-specific regulation of PDE5 by protein kinase G allows selective cGMP-mediated regulation of platelet functions. Proc Natl Acad Sci USA 105: 13650-13655, 2008.
45. Wood JS, Yan X, Mendelow M, Corbin JD, Francis SH, Lawrence DS. Precision substrate targeting of protein kinases. The cGMP- and cAMP-dependent protein kinases. J Biol Chem 271: 174-179, 1996.
46. Yang L, Liu G, Zakharov SI, Bellinger AM, Mongillo M, Marx SO. Protein kinase G phosphorylates Cav1.2 alpha1c and beta2 subunits. Circ Res 101: 465-474, 2007. (Pubitemid 47347877)
47. Yellon DM, Hausenloy DJ. Myocardial reperfusion injury. N Engl J Med 357: 1121-1135, 2007.
48. Zhao L, Long L, Morrell NW, Wilkins MR. NPR-A-Deficient mice show increased susceptibility to hypoxia-induced pulmonary hypertension. Circulation 99: 605-607, 1999.
49. Zhao ZQ, Corvera JS, Halkos ME, Kerendi F, Wang NP, Guyton RA, Vinten-Johansen J. Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning. Am J Physiol Heart Circ Physiol 285: H579-H588, 2003.